Minimising Unnecessary Mastectomies in a Predominantly Chinese Community

Table 1

Comparison of published data for BCT rates.

Author	Centre/country/study period		Characteristics	% BCT
Predominantly Chinese populations
Sim et al. [11]	National Cancer Centre, Singapore (2001–2010)	5130	Stages 0–IV	29.2%
Wang et al. [12]	Changi General Hospital, Singapore (2002–2008)	761	Stages 0–IV	23.3%
Chang et al. [13]	National University Hospital, Singapore (1990–2007)	2449	Stages 0–IV	29.2%
Yip et al. [14]	University of Malaya Medical Centre (2001–2005)	953	T1, T2	29.7%
Yau et al. [15]	Pamela Y. Nethersole Eastern Hospital, Hong Kong (1994–2007)	2375	T1, T2	30%
International/Western
Agarwal et al. [6]	SEER database (1998–2008)	132 149	Tumour ≤4 cm, ≤3 lymph node +	70%
McGuire et al. [16]	Moffitt Cancer Centre, FL, USA (1994–2007)	5865	Stages 0–IV	63.7%
Lee et al. [17]	University of Michigan Medical Centre, Michigan, USA (2003–2005)	993	Tis-T4	63%
Garcia-Etienne et al. [18]	EUSOMA (2003–2010)	15 369	Stages 0, I, and II (stage III, T3/T4 excluded)	73.3%
Current study	MammoCare, Singapore (2008–2011)	125	Symptomatic	82.4%
		46	Screen detected	95.6%
		171	Tis-T4	85.9%

BCT: breast conservation treatment.
SEER: surveillance, epidemiology, and end-result.
FL: Florida, USA: United States of America.
EUSOMA: European Society of Breast Cancer Specialists.